Objective: To report the hearing results of cochlear implantation simultaneous to vestibular schwannoma (VS) resection by means of a translabyrinthine approach in patients with normal contralateral hearing. Methods: This was a prospective study including adults with sporadic VS. Tumors were resected by means of a modified translabyrinthine approach with preservation of the cochlear nerve. Results: A total of 13 patients underwent cochlear implantation. At 14 months, the mean pure-tone audiogram was 56 dB. The mean speech recognition was 80%. Cochlear implantation provides monaural and binaural benefits in all the conditions tested, including sound localization. Conclusions: Cochlear implantation can be safely performed simultaneously to VS resection with satisfactory hearing results provided that the cochlear nerve is anatomically intact.

1.
Ahmad RA, Sivalingam S, Topsakal V, Russo A, Taibah A, Sanna M: Rate of recurrent vestibular schwannoma after total removal via different surgical approaches. Ann Otol Rhinol Laryngol 2012;121:156-161.
2.
Aristegui M, Denia A: Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: report of two cases (neurofibromatosis type 2 and unilateral vestibular schwannoma). Otol Neurotol 2005;26:205-210.
3.
Arndt S, Aschendorff A, Laszig R, Beck R, Schild C, Kroeger S, et al: Comparison of pseudobinaural hearing to real binaural hearing rehabilitation after cochlear implantation in patients with unilateral deafness and tinnitus. Otol Neurotol 2011;32:39-47.
4.
Arriaga MA, Marks S: Simultaneous cochlear implantation and acoustic neuroma resection: imaging considerations, technique and functional outcome. Otolaryngol Head Neck Surg 1995;112:325-328.
5.
Arts RA, George EL, Stokroos RJ, Vermeire K: Review: cochlear implants as a treatment of tinnitus in single-sided deafness. Curr Opin Otolaryngol Head Neck Surg 2012;20:398-403.
6.
Carlson ML, Breen JT, Driscoll CL, Link MJ, Neff BA, Gifford RH, et al: Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance. Otol Neurotol 2012;33:853-862.
7.
Celis-Aguilar E, Lassaletta L, Gavilán J: Cochlear implantation in patients with neurofibromatosis type 2 and patients with vestibular schwannoma in the only hearing ear. Int J Otolaryngol 2012;2012:157497.
8.
Di Lella F, Merkus P, Di Trapani G, Taibah A, Guida M, Sanna M: Vestibular schwannoma in the only hearing ear: role of cochlear implants. Ann Otol Rhinol Laryngol 2013;122:91-99.
9.
Free RH, Falcioni M, Di Trapani G, Giannuzzi AL, Russo A, Sanna M: The role of subtotal petrosectomy in cochlear implant surgery - a report of 32 cases and review on indications. Otol Neurotol 2013;34:1033-1040.
10.
Hassepass F, Arndt S, Aschendorff A, Laszig R, Wesarg T: Cochlear implantation for hearing rehabilitation in single-sided deafness after translabyrinthine vestibular schwannoma surgery. Eur Arch Otorhinolaryngol 2016;273:2373-2383.
11.
Kamal SM, Robinson AD, Diaz RC: Cochlear implantation in single-sided deafness for enhancement of sound localization and speech perception. Curr Opin Otolaryngol Head Neck Surg 2012;20:393-397.
12.
Kanzaki J, Tos M, Sanna M, Moffat DA, Monsell EM, Berliner KI: New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol 2003;24:642-649.
13.
Kompis M, Pfiffner F, Krebs M, Caversaccio M: Factors influencing the decision for BAHA in unilateral deafness: the Bern Benefit in Single-Sided Deafness Questionnaire. Adv Otorhinolaryngol 2011;71:103-111.
14.
Kuo SC, Gibson WP: The role of promontory stimulation after labyrinthectomy. J Laryngol Otol 1991;105:729-731.
15.
Kuo SC, Gibson WP: The role of promontory stimulation test in cochlear implantation. Cochlear Implants Int 2002;3:19-28.
16.
Lassaletta L, Aristegui M, Medina M, Aranguez G, Pérez-Mora RM, Falcioni M, Gavilán J, Piazza P, Sanna M: Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best ear and in patients with NF2. Eur Arch Otorhinolaryngol 2016;273:27-35.
17.
Leake PA, Hradek GT, Snyder RL: Chronic electrical stimulation by a cochlear implant promotes survival of spiral ganglion neurons after neonatal deafness. J Comp Neurol 1999;412:543-562.
18.
Lloyd SK, Glynn FJ, Rutherford SA, King AT, Mawman DJ, O'Driscoll MP, et al: Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2. Otol Neurotol 2014;35:43-51.
19.
Lustig LR, Yeagle J, Driscoll CL, Blevins N, Francis H, Niparko JK: Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma. Otol Neurotol 2006;27:512-518.
20.
Magnan J, Parikh B, Miyazaki H: Nerve monitoring for cerebellopontine angle surgery; in Magnan J, Parikh B, Miyazaki H (eds): Functional Surgery of Cerebellopontine Angle by Minimally Invasive Retrosigmoid Approach. New Delhi, Jaypee Brothers Medical Publishers, 2013, pp 19-28.
21.
Nilsson M, Soli SD, Sullivan J: Development of a hearing in noise test for the measurement of speech reception threshold. J Acoust Soc Am 1994;95:1085-1099.
22.
Odat HA, Piccirillo E, Sequino G, Taibah A, Sanna M: Management strategy of vestibular schwannoma in neurofibromatosis type 2. Otol Neurotol 2011;32:1163-1170.
23.
Polo R, Medina MD, Arístegui M, Lassaletta L, Gutierrez A, Aránguez G, Prasad SC, Alonso A, Gavilán J, Sanna M: Subtotal petrosectomy for cochlear implantation: lessons learnt after 110 cases. Ann Otol Rhinol Laryngol 2016;125:485-494.
24.
Rabelo de Freitas M, Russo A, Sequino G, Piccirillo E, Sanna M: Analysis of hearing preservation and facial nerve function for patients undergoing vestibular schwannoma surgery: the middle cranial fossa approach versus the retrosigmoid approach - personal experience and literature review. Audiol Neurotol 2012;17:71-81.
25.
Sanna M, Khrais T, Russo A, Piccirillo E, Augurio A: Hearing preservation surgery in vestibular schwannoma: the hidden truth. Ann Otol Laryngol 2004;113:156-163.
26.
Sanna M, Mancini F, Russo A, Taibah A, Falcioni M, Di Trapani G: Management in special situations; in Sanna M, Mancini F, Russo A, Taibah A, Falcioni M, Di Trapani G (eds): Atlas of Acoustic Neuroma Microsurgery, ed 2. Stuttgart, Thieme, 2011, pp 244-267.
27.
Tysome JR, Axon PR, Donnelly NP, Evans DG, Ferner RE, O'Connor AF, Freeman SR, Gleeson M, Halliday D, Harris F, Jiang D, Kerr R, King A, Knight RD, Lloyd SK, Macfarlane R, Mannion R, Mawman D, O'Driscoll M, Parry A, Ramsden J, Ramsden R, Rutherford SA, Saeed SR, Thomas N, Vanat ZH: English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2. Otol Neurotol 2013;34:1743-1747.
28.
Tveiten OV, Carlson ML, Goplen F, Vassbotn F, Link MJ, Lund-Johansen M: Long-term auditory symptoms in patients with sporadic vestibular schwannoma: an international cross-sectional study. Neurosurgery 2015;77:218-227.
29.
Van de Heyning P, Vermeire K, Diebi M, Nopp P, Anderson I, De Ridder D: Incapacitating tinnitus in single-sided deafness treated by cochlear implantation. Ann Otol Rhinol Laryngol 2008;117:645-652.
30.
Vermeire K, Van de Heyning P: Binaural hearing after cochlear implantation in subjects with unilateral sensorineural deafness and tinnitus. Audiol Neurotol 2009;14:163-171.
31.
Vincenti V, Pasanisi E, Guida M, Di Trapani G, Sanna M: Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation. Audiol Neurotol 2008;13:273-280.
32.
Wazen JJ, Spitzer JB, Ghossaini SN, Fayad JN, Niparko JK, Cox K, et al: Transcranial contralateral cochlear stimulation in unilateral deafness. Otolaryngol Head Neck Surg 2003;129:248-254.
33.
Zannetti D, Campovecchi CB, Pasini S, Nassif N: Simultaneous translabyrinthine removal of acoustic neuroma and cochlear implantation. Auris Nasus Larynx 2008;35:562-568.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.